Key Finding
Thirty days of moxibustion at ST36 significantly reduced pain, swelling, and inflammatory markers while preserving cartilage structure through regulation of alanine, aspartate, and glutamate metabolic pathways in rats with knee osteoarthritis.
Researchers investigated whether moxibustion, a traditional Chinese medicine therapy that uses burning herbs to warm acupuncture points, could help protect knee cartilage in rats with osteoarthritis. Knee osteoarthritis causes progressive joint cartilage breakdown, leading to pain and swelling. While conventional medications offer some relief, they often have limited effectiveness and unwanted side effects.
The study used rats divided into three groups: healthy controls, untreated osteoarthritis models, and rats receiving moxibustion treatment. Researchers induced knee osteoarthritis through chemical injection, then treated one group with 30 minutes of mild moxibustion daily at the ST36 point (Stomach 36, located on the lower leg) for 30 consecutive days.
Results showed that moxibustion provided significant benefits. Treated rats experienced reduced knee swelling, improved pain thresholds, and decreased levels of inflammatory markers (MMP-13 and IL-1β) in joint tissue. Microscopic examination revealed that moxibustion helped preserve cartilage structure, reduced inflammation and scarring, and improved the health of cartilage cells. The researchers discovered that moxibustion works partly by regulating amino acid metabolism pathways—specifically alanine, aspartate, and glutamate—which play important roles in cartilage health and immune response.
For patients with knee osteoarthritis, this research suggests moxibustion may offer a non-drug approach to managing pain, reducing inflammation, and potentially slowing cartilage deterioration. The treatment appears to work through multiple biological mechanisms, including immune system modulation and metabolic regulation. If you're considering moxibustion for knee osteoarthritis, seek treatment from a licensed acupuncturist with proper training in moxibustion techniques.
This animal study investigated moxibustion's cartilage-protective mechanisms in sodium iodoacetate-induced knee osteoarthritis using Sprague-Dawley rats (n=3 groups: normal, KOA model, moxibustion). The treatment protocol consisted of 30-minute daily mild moxibustion at ST36 for 30 consecutive days. Liquid chromatography-mass spectrometry analyzed cartilage amino acid metabolites.
Moxibustion produced statistically significant improvements: increased mechanical pain threshold (P=0.045), reduced knee diameter (P<0.0001), decreased synovial MMP-13 (P=0.0004) and IL-1β (P=0.002). Histological analysis demonstrated preserved hyaline cartilage structure, reduced inflammatory infiltration, and improved chondrocyte morphology with decreased nuclear pyknosis and organelle damage. Metabolomic analysis revealed downregulated alanine and glutamine levels (P<0.0001), with KEGG pathway analysis identifying alanine, aspartate, and glutamate metabolism as the primary affected pathways.
Clinical implications: ST36 moxibustion demonstrates multi-modal therapeutic effects through metabolic regulation of amino acid pathways, suggesting potential for cartilage protection beyond symptomatic relief in knee osteoarthritis management.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Combined acupuncture and moxibustion was the most effective intervention for reducing arm circumference in breast cancer-related lymphedema, while electroacupuncture was superior for pain relief and improving shoulder abduction range of motion when added to conventional rehabilitation.
📌 Zhoutian moxibustion covering both the Governor and Conception Vessels achieved a 90% effective rate in ankylosing spondylitis patients and produced significantly greater reductions in pain scores and serum inflammatory markers (IL-1β, IL-18, TNF-α) compared to Governor Vessel moxibustion alone.
📌 Ma's bamboo-based medicinal moxibustion provided pain relief equivalent to acupuncture at 14 days, while delivering superior improvements in lumbar dysfunction and daily living ability by day 28 in patients with lumbar disc herniation.